MED1 and breast carcinoma: These results explicitly show that leptin induces phosphorylation, nuclear accumulation, promoter recruitment of Med1 in breast cancer cells and inhibition of ERbB kinases abrogates leptin-stimulated Med1 phosphorylation as well as its transactivation function.